Eric T Harvill

Author PubWeight™ 59.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 2014 1.76
2 Role of antibodies in immunity to Bordetella infections. Infect Immun 2003 1.71
3 Molecular signature of hypersaline adaptation: insights from genome and proteome composition of halophilic prokaryotes. Genome Biol 2008 1.64
4 Modeling systems-level regulation of host immune responses. PLoS Comput Biol 2007 1.56
5 Genomic and genetic analysis of Bordetella bacteriophages encoding reverse transcriptase-mediated tropism-switching cassettes. J Bacteriol 2004 1.36
6 Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol 2003 1.35
7 Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 2005 1.32
8 Role of Bordetella O antigen in respiratory tract infection. Infect Immun 2003 1.32
9 The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun 2006 1.31
10 Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens. BMC Genomics 2012 1.30
11 Evolution and emergence of Bordetella in humans. Trends Microbiol 2005 1.25
12 Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun 2005 1.23
13 MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling. Infect Immun 2005 1.22
14 Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine 2010 1.18
15 Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis 2004 1.14
16 Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect Immun 2004 1.13
17 Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun 2002 1.13
18 Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence. J Immunol 2005 1.13
19 Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. Eur J Immunol 2004 1.10
20 The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. Infect Immun 2007 1.09
21 The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. J Immunol 2005 1.08
22 pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun 2004 1.06
23 O antigen protects Bordetella parapertussis from complement. Infect Immun 2008 1.04
24 Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol 2008 1.03
25 Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One 2009 1.01
26 Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect Immun 2005 1.00
27 Evolution of acute infections and the invasion-persistence trade-off. Am Nat 2009 0.98
28 Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun 2009 0.97
29 Pertussis pathogenesis--what we know and what we don't know. J Infect Dis 2014 0.92
30 Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxin. J Infect Dis 2007 0.91
31 Intracellular trafficking of Bordetella pertussis in human macrophages. Infect Immun 2010 0.91
32 Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. Microbes Infect 2007 0.91
33 Comparative role of immunoglobulin A in protective immunity against the Bordetellae. Infect Immun 2007 0.90
34 O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS One 2009 0.90
35 Constraint-based network model of pathogen-immune system interactions. J R Soc Interface 2008 0.89
36 Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci 2010 0.89
37 Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. Infect Immun 2013 0.89
38 IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response. J Immunol 2009 0.89
39 Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun 2010 0.89
40 Lack of cross-protection against Bordetella holmesii after pertussis vaccination. Emerg Infect Dis 2012 0.88
41 The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. Infect Immun 2009 0.87
42 Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect Immun 2004 0.87
43 Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS One 2009 0.87
44 A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo. PLoS One 2012 0.85
45 CD11b is required for the resolution of inflammation induced by Bordetella bronchiseptica respiratory infection. Cell Microbiol 2006 0.85
46 Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect Immun 2009 0.84
47 Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica. Infect Immun 2009 0.83
48 Bordetella pertussis acquires resistance to complement-mediated killing in vivo. Infect Immun 2003 0.82
49 IEIIS Meeting minireview: Bordetella evolution: lipid A and Toll-like receptor 4. J Endotoxin Res 2007 0.81
50 Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. J Immunol 2011 0.81
51 Phenotypic and genomic analysis of hypervirulent human-associated Bordetella bronchiseptica. BMC Microbiol 2012 0.80
52 Identifying the age cohort responsible for transmission in a natural outbreak of Bordetella bronchiseptica. PLoS Pathog 2010 0.79
53 Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen. Infect Immun 2012 0.79
54 sigE facilitates the adaptation of Bordetella bronchiseptica to stress conditions and lethal infection in immunocompromised mice. BMC Microbiol 2012 0.79
55 Resident microbiota affect Bordetella pertussis infectious dose and host specificity. J Infect Dis 2013 0.78
56 Horizontally acquired divergent O-antigen contributes to escape from cross-immunity in the classical bordetellae. BMC Evol Biol 2013 0.77
57 Identification of a CO2 responsive regulon in Bordetella. PLoS One 2012 0.77
58 Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic. J Biol Chem 2010 0.76
59 Teaching ethical aptitude to graduate student researchers. Account Res 2013 0.75